Category Archives: Retinitis Pigmentosa

DEVONPORT Aquatic swimmer Jacob Templeton will this week head to Adelaide for the 2013 Energy Australia Swimming Championships. DEVONPORT Aquatic swimmer Jacob Templeton will this week head to Adelaide for the 2013 Energy Australia Swimming Championships. Jacob has been classified as a multi-class athlete, due to a degenerative eye disease called retinitis pigmentosa. This means that he will swim in the visually impaired S13 class against Australia's best from the recent Paralympics, including world record holder Matthew Cowdrey. With the Devonport Aquatic Centre being reconstructed, Jacob has had to travel from Burnie to Launceston to train. He is also a year 12 student at St Brendan-Shaw College, which means he has had to overcome the difficult task of balancing his study and training loads. Racing in his favoured events _ the 50 metre and 100m freestyle and butterfly, and the 200m individual medley _ Jacob is keen to show his competition that he is up to the challenge. He has done the majority of his training alone and will use this as encouragement and motivation come race day. Olympic stars including James Magnussen and Alicia Coutts will be competing at the championships, as the multi-class events are intertwined with those … Continue reading →

In an effort to fund cutting-edge research targeting vision-robbing retinal diseases affecting more than 10 million Americans, the Foundation Fighting Blindness will host its 7th Annual Houston VisionWalk on Saturday, October 4, at Discovery Green Park. The 5K walkathon aims to raise $120,000 for research that will lead to preventions, treatments and cures for diseases such as retinitis pigmentosa (RP), age-related macular degeneration, Usher syndrome and Stargardt disease. These sight-stealing diseases affect people of all races and ethnicities, young and old. "Sight is something you can learn to live without, but, of course, we don't want Brendan to have to miss out on anything," VisionWalk Team Captain Anne Doventry says of her son. "That is why our family decided to participate in Visionwalk. While we know Brendan is going to have an amazing future with or without sight, we want him to have every chance to fulfill his dreams." Doventry is hopeful because the Foundation Fighting Blindness funds many avenues of promising research, including a breakthrough gene therapy which has restored vision in children and young adults in clinical trials. "VisionWalk is an opportunity to take action in support of advancing research and move one step closer to a cure," … Continue reading →

Part 1- Retinitis Pigmentosa Treatment (in Arabic) - great improvement Algerian patient's testimonial on the Retinitis Pigmentosa Therapy with Electro-Acupuncture in Firatli Clinic. He shows his medical test results that compare... By: Osman Fratl … Continue reading →

Retinitis Pigmentosa Treatment From Dr. Andy Rosenfarb http:--www.RetinitisPigmentosaTreatment.com 908-818-0701. By: Dr. Andy Rosenfarb … Continue reading →

April Lufriu Talks Retinitis Pigmentosa Treatment with Dr. Andy Rosenfarb http:--www.RetinitisPigmentosaTreatment.com 908-818-0701 April Lufriu on Retinitis Pigmentosa treatment from Dr. Andy Rosenfarb. By: Dr. Andy Rosenfarb … Continue reading →

GeneAnalytics - Disease gene set analysis - Retinitis Pigmentosa This case demonstrates how GeneAnalytics can be used in drug discovery. We will use a gene set associated with Retinitis pigmentosa to identify cells associated with the disease, disease mechanisms... By: LifeMap Discovery … Continue reading →

Woche des Sehens - Retinitis Pigmentosa Sehbehinderung im Alltag Ein Film der Woche des Sehens Etwa 285 Millionen Menschen weltweit sind Sehbehindert. In Deutschland sind circa eine Millionen Menschen betroffen. Dabei knnen die... By: WochedesSehens … Continue reading →

Retinitis Pigmentosa Treatment (in arabic )- FIRATLI CLINIC Treatment of Retinitis Pigmentosa ; reviews of a syrian patient after the treatment. Web-Site RP treatment : http://www.retinitispigmentosacure.com Stargardt's trea... By: Osman Fratl … Continue reading →

Interview Dr.MS Basu, Explaining Retinitis Pigmentosa its Treatments in Ayurveda By: Mahendra Singh Basu … Continue reading →

By RTT News, September 12, 2014, 07:19:00 AM EDT (RTTNews.com) - QLT Inc. ( QLTI ) Friday reported positive data from its Phase 1b retreatment trial with oral synthetic Cis-Retinoid or QLT091001 in patients with Leber Congenital Amaurosis or LCA or Retinitis Pigmentosa or RP. The results showed clinically significant improvements in visual fields with repeated dosing of QLT091001 in both LCA and RP patients with RPE65 or LRAT mutations. There was also a slight positive effect on visual acuity in both patient groups. The Phase 1b retreatment trial was a multicenter, open-label extension study in which LCA or RP patients with RPE65 or LRAT mutations who had been treated with a single course of QLT091001 in the company's previously completed Phase 1b study, received up to three 7-day courses of QLT091001 to evaluate visual outcomes and safety following retreatment. For comments and feedback: contact editorial@rttnews.com http://www.rttnews.com Follow this link: QLT Reports Positive Results From Phase 1b Trial With QLT091001 … Continue reading →